Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

but Lupkynis will eventually be used by many with severe LN because it’s cost effective re dialysis costs ( $120k a yr ) … let alone what life is like for dialysis patients

EVENTUALLY !!!!! ???? Why not immediately, so as to prevent the disease progressing to the "severe" stage. A doctor's responsibility is to deliver the most beneficial treatment available, irrespective of how the insurance company's bottom line is impacted.

Patients and families will not be passive, knowing that they're being denied the best treatment available.

Any speculation on the timing of treatment is highly dubious at this point.